CC BY-NC-ND 4.0 · International Journal of Epilepsy 2016; 03(01): 012-019
DOI: 10.1016/j.ijep.2016.02.001
Original Article
Thieme Medical and Scientific Publishers Private Ltd.

Effect of aqueous extract of Moringa oleifera leaves on pharmacological models of epilepsy and anxiety in mice

Suvarna P. Ingale
1   SCES's Indira College of Pharmacy, Pune 411033, India
Foram P. Gandhi
1   SCES's Indira College of Pharmacy, Pune 411033, India
› Author Affiliations
Further Information

Publication History

Received: 28 September 2015

Accepted: 03 February 2016

Publication Date:
08 May 2018 (online)


Objective Among the psychiatric co-morbidities in epilepsy, anxiety disorders are highly frequent and have profound influence on the quality of life of epilepsy patients. Moringa oleifera Lam. (Moringaceae) is used in traditional medicine to treat various ailments including anxiety and epilepsy. However, no scientific evidence exists to support its use. We studied antiepileptic and anxiolytic activities of aqueous extract of Moringa oleifera Lam. leaves (AEMO).

Methods Antiepileptic activity was evaluated using pentylenetetrazole (PTZ) induced seizure and maximum electroshock (MES) induced seizure test and anxiolytic activity was evaluated using elevated plus maze, light/dark box and hole board test.

Results In present study, AEMO (250, 375 and 500 mg/kg, i.p.) demonstrated significant antiepileptic and anxiolytic effects. To study involvement of GABA in anxiolytic and antiepileptic activity of AEMO, we also evaluated effect of AEMO on Baclofen induced catatonia, a GABA mediated behavior, wherein AEMO significantly potentiated (preponed) baclofen induced catatonia, which is suggestive of its GABA mimetic action.

Conclusion Thus, it may be concluded that aqueous extract of M. oleifera possess anxiolytic and antiepileptic effects possibly mediated via of GABA mimetic action and these findings authenticate the traditional claims about use of Moringa oleifera in treatment of epilepsy and anxiety.

  • References

  • 1 Barragán E. Epilepsy and related psychiatric conditions. Rey JM. IACAPAP e-Textbook of Child and Adolescent Mental Health. 2012. International Association for Child and Adolescent Psychiatry and Allied Professions; Geneva: 1-12
  • 2 Ozalp E. Anxiety disorders in epilepsy. Szirmai Ã. Anxiety Related Disorders. 2011. InTech; Europe: Available from:
  • 3 Kulkarni SK, Reddy DS. Animal behavioral models for testing anti-anxiety agents. Methods Find Exp Clin Pharmacol 18 1996; 219-230
  • 4 Yadav AV, Kawale LA, Nade VS. Effect of Morus alba L. (mulberry) leaves on anxiety in mice. Ind J Pharmacol 40 2008; 32-36
  • 5 Milutin N, Miroslava J, Sreten V, Nenad N, Periša S. Anxiety in epileptic patients. Psychiatria Danubina 23 2011; 264-269
  • 6 Goyal BR, Agarwal BB, Goyal RK, Mehta A. Phyto-pharmacology of Moringa oleifera Lam: an overview. Nat Prod Rediance 6 2007; 347-353
  • 7 Mishra G, Singh P, Verma R, Kumar S, Shrivastav S, Khosa RL. Traditional uses, phytochemistry and pharmacological properties of Moringa oleifera plant: an overview. Der Pharmacia Lettre 3 2011; 141-164
  • 8 Khawaja TM, Tahira M, Ikram UH. Moringa oleifera: a natural gift – a review. J Pharm Sci Res 2 2010; 775-781
  • 9 Bakre AG, Aderibigbe AO, Ademowo OG. Studies on neuropharmacological profile of ethanol extract of Moringa oleifera leaves in mice. J Ethnopharmacol 149 2013; 783-789
  • 10 Harborne JB. Jackman H. Phytochemical Methods. 1973: 70 London:
  • 11 Marinova D, Ribarova F, Atanassova M. Total phenolics and total flavonoids in Bulgarian fruits and vegetables. J Univ Chem Technol Metall 40 2005; 255-260
  • 12 Shamsa F, Monsef HR, Ghamooshi R, Verdian R, Mohammad R. Spectrophotometric determination of total alkaloids in Peganum harmala L. using bromocresol green. Res J Phytochem 1 2007; 79-82
  • 13 Jain NN, Ohal CC, Shroff RH, Somani RS, Kasture VS, Kasture SB. Clitorea ternatea and the CNS. Pharmacol Biochem Behav 75 2003; 529
  • 14 Swinyard EA, Brown WC, Goodman LS. Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106 1952; 319-330
  • 15 Kasture SB, Mandhane SN, Chopde CT. Baclofen induced catatonia: modification by serotonergic agents. Neuropharmacology 35 1996; 595-598
  • 16 Silva SR, Futuro-Neto HA, Pires JG. Effects of 5-HT3 receptor antagonists on neuroleptic-induced catalepsy in mice. Neuropharmacology 34 1995; 97-99
  • 17 Spinella M. herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav 2 2001; 524-532
  • 18 Mahendran G, Thamotharan G, Sengottuvelu S, Narmatha Bai V. Evaluation of anticonvulsant, sedative, anxiolytic, and phytochemical profile of the methanol extract from the aerial parts of Swertia corymbosa (Griseb.) Wight ex C.B. Clarke. Biomed Res Int 2014 2014; 542385 10.1155/2014/542385
  • 19 Putnam TJ, Merritt HH. Experimental determination of the anticonvulsant properties of some phenyl derivatives. Science 85 1937; 525-526
  • 20 Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50 2002; 105-123
  • 21 Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19 1978; 409-428
  • 22 Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 284 1998; 474-479
  • 23 Raza M, Shaheen F, Choudhary MI. et al. Anticonvulsant activities of ethanolic extract and aqueous fraction isolated from Delphinium denudatum . J Ethnopharmacol 78 2001; 73-78
  • 24 White HS. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia 38 1997; S9-S17
  • 25 File SE, Lippa AS, Beer B, Lippa MT. Animal tests of anxiety. Curr Protoc Neurosci. 2004 Chapter 8: Unit 8.3
  • 26 Crawley JN. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9 1985; 37-44
  • 27 Shimada T, Matsumoto K, Osanai M, Matsuda H, Terasawa K, Watanabe H. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol 26 1995; 205-210
  • 28 Wei XY, Yang JY, Wang JH, Wu CF. Anxiolytic effect of saponins from Panax quinquefolium in mice. J Ethnopharmacol 111 2007; 613-618
  • 29 Möhler H. GABAA receptors in central nervous system disease: anxiety, epilepsy, and insomnia. J Recept Signal Transduct 26 2006; 731-740
  • 30 Kwan 1 P, Sills GJ, Brodie MJ. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Therapeut 90 2001; 21-34
  • 31 Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat 11 2015; 165-175
  • 32 Jäger AK, Saaby L. Flavonoids and the CNS. Molecules 16 2011; 1471-1485